Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Our volunteers generously give us their time, skills and experience to tell people about our work, and to help us raise vital funds for research into better treatments and ultimately a cure for T1D.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > JDRF sponsors Daphne Jackson Fellowship
Have you taken a break from your research career and are now looking to return to work? Are you seeking an opportunity to re-establish your skills and make a positive impact in your field?
We are delighted to announce our latest partnership funding opportunity, offered through the Daphne Jackson Trust. The Breakthrough T1D UK-sponsored Fellowship is for a researcher with an interest in type 1 diabetes to return to work after a career break and make a difference in their field.
There are around 400,000 people living with type 1 diabetes in the UK and currently there is no cure. Here at JDRF, we’re committed to supporting research to improve the lives of people affected by type 1 diabetes and one day eradicate the condition for good.
Rachel Connor, Director of Research Partnerships at JDRF UK said, “JDRF is very excited to be working with the Daphne Jackson Trust to support people returning to type 1 diabetes research.”
These Fellowships offer three-year part-time funding for individuals wishing to return to research after a career break of two years or more. The Fellowships must be undertaken at a UK university and involve a challenging research project that addresses a question of relevance to type 1 diabetes and its associated complications. Fellows additionally benefit from an individually tailored retraining programme throughout the course of their Fellowship.
Helen Marsh, Trust Manager at the Daphne Jackson Trust said, “We are very excited to be working with JDRF and delighted that they are sponsoring a Daphne Jackson Fellowship, supporting a research returner to get back into their career. JDRF make a real difference to people’s lives with type 1 diabetes, and their research is crucial.”
For more details about the eligibility criteria and the application process, please visit: www.daphnejackson.org. For further information before submitting an application, please contact the Daphne Jackson Trust via email at djmft@surrey.ac.uk.
Researchers funded by Breakthrough T1D in America have used small, electrical implant systems in lab-grown, insulin-producing cells.
New research suggests that B cells play a major role in damaging protective immune cells called Tregs. Protecting Tregs could help protect insulin-producing cells in the early stages of T1D.
A major UK study has shown that screening children for type 1 diabetes (T1D) can identify the condition in its earliest stages, before symptoms appear, offering families time, choices, and hope.
The European Commission has approved Teizeild, the European brand name for the immunotherapy teplizumab, for use in people with stage 2 type 1 diabetes (T1D). This marks an important step forward in efforts to delay the progression of the condition.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
